Target intelligence / Profile preview

Vacuolar protein sorting 45 homolog (VPS45)

Target
VPS45
Molecular classification
Vesicular transport protein, Sec1/Munc18 (SM) protein family, Other
01

Overview

Vacuolar protein sorting 45 homolog (VPS45) is a cytosolic protein belonging to the Sec1/Munc18 (SM) protein family, and plays a critical regulatory role in vesicle-mediated protein sorting, primarily within the endosomal system[1][3][7]. VPS45 functions as a key organizer of membrane trafficking between early endosomes and the trans-Golgi network by regulating the assembly of SNARE complexes and interacting with Rab5 effectors such as Rabenosyn-5 to facilitate endosomal fusion and receptor recycling[4][5]. It is required for neutrophil function, innate immunity, and proper hematopoiesis[1][2][5]. Mutations in VPS45 can disrupt endosomal-lysosomal transport, leading to severe congenital neutropenia, bone marrow fibrosis, myelofibrosis, platelet aggregation abnormalities, and (in some cases) neurological impairment[1][2][5]. Loss of VPS45 function can cause defective Rab5-to-Rab7 conversion, trapping cargo in early endosomes and impairing lysosomal delivery[5]. Knockout in mice is embryonically lethal, underscoring its essential role in development[5]. No specific drugs targeting VPS45 are currently identified, but the gene and its mutations serve as important biomarkers for inherited bone marrow failure syndromes, particularly for patient diagnosis and selection for bone marrow transplantation[2][5].

Other names
VPS45Vacuolar protein sorting-associated protein 45H-Vps45Leucocyte vacuolar protein sorting 45VPS45AVPS45BVacuolar protein sorting 45 homolog (S. cerevisiae)Vacuolar protein sorting 45A (yeast homolog)H1
02

Biological functions

Vesicle-mediated protein sortingEndosomal traffickingMaintenance of endolysosomal compartmentsProtein traffickingRegulation of immune cell homeostasisCell-surface receptor recyclingEmbryonic developmentHematopoiesis
03

Disease associations

Severe congenital neutropeniaMyelofibrosisBone marrow failurePlatelet disorder (thrombasthenia)Neurological impairmentNon-small cell lung cancerOther
04

Safety considerations

Null—no specific drug-targeted therapies presently known; genetic mutations cause severe immunodeficiency and bone marrow failure[2][5].
05

Biomarkers

Mutations in VPS45 are biomarkers for severe congenital neutropenia and bone marrow failure syndromes[2][5].

Beyond the preview

Go deeper on Vacuolar protein sorting 45 homolog (VPS45).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar protein sorting 45 homolog (VPS45).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call